ARTICLE | Clinical News
Soliris eculizumab regulatory update
February 20, 2012 8:00 AM UTC
The Scottish Medicines Consortium recommended against the use of Soliris eculizumab on the National Health Service (NHS) in Scotland to treat patients with atypical hemolytic uremic syndrome (aHUS) - ...